Home > Boards > US Listed > Biotechs > 22nd Century Group (XXII)

$XXII conclusion from SA author:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Atlanta1 Member Profile
 
Followed By 182
Posts 31,565
Boards Moderated 3
Alias Born 04/08/02
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/6/2020 1:14:22 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 7:31:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 7:01:16 AM
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020 GlobeNewswire Inc. - 8/6/2020 7:00:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/31/2020 7:41:24 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/21/2020 3:46:37 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2020 10:40:44 AM
22nd Century Group to Host Webcast of 2020 Second Quarter Results GlobeNewswire Inc. - 7/9/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2020 4:35:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 4:18:53 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 6/11/2020 10:52:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 4:14:01 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/5/2020 9:33:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2020 7:00:56 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2020 4:28:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2020 4:55:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2020 12:04:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 7:16:14 AM
22nd Century Group Reports First Quarter 2020 Financial Results Business Wire - 5/7/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 4:31:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2020 4:30:58 PM
22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials Business Wire - 4/30/2020 2:00:00 PM
22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020 GlobeNewswire Inc. - 4/28/2020 6:50:10 AM
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application GlobeNewswire Inc. - 4/17/2020 12:15:47 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/8/2020 4:31:09 PM
Atlanta1   Tuesday, 11/19/13 03:09:07 PM
Re: Atlanta1 post# 3179
Post # of 51209 
$XXII conclusion from SA author:

Conclusion


At this point Wall Street doesn't understand 22nd Century Group's potential monopoly on a good part of the reduced risk cigarette market, or the smoking cessation market. Nor do investors yet realize the significance of the British American Tobacco licensing deal and the FDA's anticipation of 22nd Century submitting a modified risk application. 22nd Century is addressing a $700 billion market, and even if the company only achieves 1% penetration, investors would still realize at least a 20X return. From my perspective, the company's profitability, healthy balance sheet and valuable IP portfolio makes this an ideal asymmetrical trade, huge upside potential, with very little downside risk.


http://seekingalpha.com/article/1849101-22nd-century-is-worth-twice-todays-shareprice



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist